SpineGuard has been granted a patent by the US Patent and Trademark Office (USPTO) for the application of its Dynamic Surgical Guidance (DSG) technology to bone quality measurement.
“Because of population aging, orthopaedists and neurosurgeons are treating an increasing number of osteoporotic patients, and they are expressing the need to precisely measure the bone quality. A widely shared opinion amongst surgeons is that the existing standard of care—known as a DEXA scan—only brings an uncertain answer to this growing need.” says Pierre Jérôme, chief executive officer and co-founder of SpineGuard. “This grant from the US Patent Office follows previous patent grants in China and Japan. It confirms the potential of SpineGuard’s DSG technology for this very promising new application,” says Pierre Jérôme, chief executive officer and co-founder of SpineGuard.
“We believe that the DSG technology can allow surgeons facing these skeletal pathologies to evaluate the bone density of their patients intraoperatively in a much more precise anatomical area and in doing so, to fine-tune their surgical strategy,” concludes Stéphane Bette, co-founder, chief technology officer and US general manager of SpineGuard. “For spine surgeries, this will ease the choice of the implants, their size, their diameter, their location and if cement should be used or not.”
